Found 412 hits.
| 435. | Baumann, K.*, Marcelino, J.*, Stahl Skov, P. S., Santos, M., Wyroslak, I., Scheffel, J., Altrichter, S., Woetmann, A., Costa, C., and Maurer, M.+: Autologous serum skin test reactions in chronic spontaneous urticaria differ from heterologous cell reactions. J. Eur. Acad. Dermatol. Venereol. 2021: 35; 1338-1345. IF: 9.23 |
o.435
|
441. |
Metz, M., Altrichter, S., Buttgereit, T., Fluhr, J. W., Fok, J. S., Hawro, T., Jiao, Q., Kolkhir, P., Krause, K., Magerl, M., Pyatilova, P., Siebenhaar, F., Su, H., Terhorst-Molawi, D., Weller, K., Xiang, Y.-K., and Maurer, M.+: The diagnostic workup in chronic spontaneous urticaria – what to test and why. J. Allergy Clin. Immunol. Pract. 2021: 9; 2274-2283. IF: 11.02 |
o.441
|
564. |
Buttgereit, T., Salameh, P., Sydorenko, O., Zuberbier, T., Metz, M., Weller, K., and Maurer, M.+: The 7-day recall period version of the urticaria control test – UCT7. J. Allergy Clin. Immunol. 2023: 152; 1210-1217. IF: 11.40 |
o.564
| 72(a) | Metz, M., Gimenez-Arnau, A., Borzova, E., Grattan, C. E. H., Magerl, M., and Maurer, M.+: Comment on “Is the autologous plasma skin test in patients with chronic urticaria really useless? J. Allergy Clin. Immunol. 2009: 123; 1417 |
| 192 | Darlenski, R., Kazandjieva, J., Fluhr, J. W.+, Maurer, M. and Tsankov, N.: Lactic acid sting test does not differentiate between facial and generalized skin functional impairment in sensitive skin in atopic dermatitis and rosacea. J. Dermatol. Sci. 2014: 76; 151-153. IF: 3.42 |
|
575. |
Salameh, P., Gutsche, A., Aulenbacher, F., Buttgereit, T., Weller, K., Siebenhaar, F., and Maurer, M.+: Urticaria control test real-world performance: a post hoc analysis. Allergy 2024: 79; 229-232. IF: TBD (IF 2023: 12.60) |
|
575.a |
Gutsche, A., Salameh, P., Aulenbacher, F., Buttgereit, T., Weller, K., Siebenhaar, F., and Maurer, M.+: Reply to: Zhang et al.: Clinical applicability of the Urticaria Control Test in patients with chronic urticaria: further evidence from 622 adult and pediatric patients with different disease subtypes. Allergy 2024: 79; 265-267. |
o.575a
|
582. |
Demir, S.+, Eyice-Karabacak, D., Kocatürk, E., Ünal, D., Toprak, İ. D., Korkmaz, P., Aslan, A. F., İmren, I. G., Dikicier, B., Kahveci, N., Öztop, N., Kara, R. Ö., İşsever, H., Maurer, M., Weller, K., and Gelincik, A.: Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study. Clin. Transl. Allergy 2024: 14; e12342. IF: TBD (IF 2023: 4.60) |
o.582
|
458. |
Marcelino, J.+*, Baumann, K.*, Skov, P. S., Pereira Santos, M. C., Wyroslak, I., Scheffel, J., Altrichter, S., Woetmann, A., Pereira-Barbosa, M., Costa, C., and Maurer, M.+: What basophil testing tells us about CSU patients – results of the CORSA study. Front Immunol. 2021: 12; 742470. IF: 8.79 |
o.458
| 288 | Ohanyan, T., Schoepke, N., Bolukbasi, B., Metz, M., Hawro, T., Zuberbier, T., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: Responsiveness and minimal important difference of the urticaria control test (UCT). J. Allergy Clin. Immunol. 2017: 140; 1710-1713. IF: 13.26 |